These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31593785)

  • 21. Extraction and downstream processing of plant-derived recombinant proteins.
    Buyel JF; Twyman RM; Fischer R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):902-13. PubMed ID: 25922318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoprotein production in moss bioreactors.
    Decker EL; Reski R
    Plant Cell Rep; 2012 Mar; 31(3):453-60. PubMed ID: 21960098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compendium on Food Crop Plants as a Platform for Pharmaceutical Protein Production.
    Gerszberg A; Hnatuszko-Konka K
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Protein Quantity and Quality-The Next Level of Plant Molecular Farming.
    Liu H; Timko MP
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Protein Production in Plants: A Brief Overview of Strengths and Challenges.
    Schillberg S; Spiegel H
    Methods Mol Biol; 2022; 2480():1-13. PubMed ID: 35616854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plants as sources of natural and recombinant anti-cancer agents.
    Buyel JF
    Biotechnol Adv; 2018; 36(2):506-520. PubMed ID: 29408560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutical discovery and production in yeast.
    Meehl MA; Stadheim TA
    Curr Opin Biotechnol; 2014 Dec; 30():120-7. PubMed ID: 25014890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolysis of recombinant proteins in bioengineered plant cells.
    Pillay P; Schlüter U; van Wyk S; Kunert KJ; Vorster BJ
    Bioengineered; 2014; 5(1):15-20. PubMed ID: 23778319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plant molecular farming: opportunities and challenges.
    Basaran P; Rodríguez-Cerezo E
    Crit Rev Biotechnol; 2008; 28(3):153-72. PubMed ID: 18937106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery and purification of plant-made recombinant proteins.
    Wilken LR; Nikolov ZL
    Biotechnol Adv; 2012; 30(2):419-33. PubMed ID: 21843625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular, biochemical, and proteomic analyses of transplastomic tobacco plants expressing an endoglucanase support chloroplast-based molecular farming for industrial scale production of enzymes.
    Fumagalli M; Gerace D; Faè M; Iadarola P; Leelavathi S; Reddy VS; Cella R
    Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9479-9491. PubMed ID: 31701198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products.
    Menary J; Hobbs M; Mesquita de Albuquerque S; Pacho A; Drake PMW; Prendiville A; Ma JK; Fuller SS
    PLoS One; 2020; 15(3):e0229952. PubMed ID: 32196508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering of Plants for Efficient Production of Therapeutics.
    Sethi L; Kumari K; Dey N
    Mol Biotechnol; 2021 Dec; 63(12):1125-1137. PubMed ID: 34398446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developments in the production of mucosal antibodies in plants.
    Vasilev N; Smales CM; Schillberg S; Fischer R; Schiermeyer A
    Biotechnol Adv; 2016; 34(2):77-87. PubMed ID: 26626615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic engineering approaches to improve posttranslational modification of biopharmaceuticals in different production platforms.
    Amann T; Schmieder V; Faustrup Kildegaard H; Borth N; Andersen MR
    Biotechnol Bioeng; 2019 Oct; 116(10):2778-2796. PubMed ID: 31237682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae.
    Barolo L; Abbriano RM; Commault AS; George J; Kahlke T; Fabris M; Padula MP; Lopez A; Ralph PJ; Pernice M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in molecular farming: key technologies, scaled up production and lead targets.
    Daniell H; Streatfield SJ; Rybicki EP
    Plant Biotechnol J; 2015 Oct; 13(8):1011-2. PubMed ID: 26387508
    [No Abstract]   [Full Text] [Related]  

  • 39. Target product selection - where can Molecular Pharming make the difference?
    Paul MJ; Teh AY; Twyman RM; Ma JK
    Curr Pharm Des; 2013; 19(31):5478-85. PubMed ID: 23394563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming.
    Makhzoum A; Benyammi R; Moustafa K; Trémouillaux-Guiller J
    BioDrugs; 2014 Apr; 28(2):145-59. PubMed ID: 23959796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.